Research | SIU School of Medicine

Trial

Internal Medicine

AstraZeneca BaxHTN: A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypert

Active recruiting

The purpose of this clinical trial is to trial is to learn more about a new, investigational, once daily medication, called baxdrostat, and its ability to lower blood pressure in individuals not responding to their current treatment.

Eligible patients include those who currently have a diagnosis of high blood pressure, despite currently taking anti-hypertensive medications.

General Results

Library Bill of Rights

The American Library Association affirms that all libraries are forums for information and ideas, and that the following basic policies should guide their services. I. Books and other library resources should be provided for the interest, information, and enlightenment of all people of the community the library serves. Materials should not be excluded because of the origin, background, or views of those contributing to their creation. II. Libraries should provide materials and information presenting all points of view on current and historical issues. Materials should not be proscribed or

Trial

Internal Medicine

ENCORE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Myco

Active recruiting

The purpose of this clinical trial is to assess the effectiveness of ARIKAYCE, inhaled once daily, in patient populations with mild and untreated MAC lung infection.

Eligible patients include those who currently have a positive MAC sputum culture and have not received treatment for their infection.

Trial

Infectious Diseases

A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with Treatment-refractory Mycobacterium aviu

Active recruiting

The purpose of this clinical trial is to assess the effectiveness of Epetraborole, taken once daily, in patient populations with treatment-refractory MAC lung disease.

Eligible patients include those who currently have a positive MAC sputum culture despite receiving a combination regimen of at least 2 antimycobacterial agents administered for at least 6 months.

Events

Brain Aging Conference - Professionals Day

The Brain Aging Conference - Professionals Day provides health care professionals an opportunity to earn continuing education credits and learn about trends and research related to caring for those with Alzheimer’s and related disorders. From an overview about Alzheimer's, managing agitation and behavior changes, updates on research opportunities, and more, this conference is designed to help you provide better treatment and care for persons with memory loss and their caregivers. This conference is approved for a maximum of 6 AMA PRA Category 1 credits.

Dates

Events

Brain Aging Conference - Professionals Day

Dates

News

Simmons Cancer Institute accepting research internship applications

Applications for the 2024 summer lab internships at Simmons Cancer Institute at SIU School of Medicine are being accepted through February 26. Four positions will be awarded on a competitive basis to qualified undergraduate college students who plan a career in medicine or research with a focus on cancer.

News